Identification and evaluation of potential microRNA markers for diagnostics in neurodegenerative diseases and correlation with other biochemical markers
PLOS One · 10.10.2025 · 20 (10) · e0333801
DOI: 10.1371/journal.pone.0333801 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 10.10.2025. Verfasst von Richard Novobilský und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Neurology, University Hospital Ostrava, Ostrava, Czech Republic. Hauptthemen laut MEDLINE: MicroRNAs, Neurodegenerative Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerstvo Zdravotnictvà Ceské Republiky.
Abstract (Originalsprache)
Objectives
MicroRNAs (miRNA) are short, non-coding RNA molecules that play a crucial role in the development of organisms and are involved in various biological processes. They are considered potential biomarkers for many diseases, including neurodegenerative diseases. This study aimed to identify a set of microRNA targets that exhibited the greatest potential in successfully distinguishing and differentiating neurodegenerative diseases and to establish a correlation between selected miRNAs across different diagnostic groups.
Methods
The study included the analysis of 126 patients. The patients were divided into five diagnostic groups – Alzheimer’s disease, non-Alzheimer’s dementia, Movement disorder, Dementia and movement disorder, and Healthy controls. The circulating RNA was isolated using the iCatcher Circulating cfRNA 1000 Kit with the iCatcher 12 automated isolator. The determination of microRNA was performed by TT-qPCR in the CFX96™ Real-Time Detection System. The concentrations of the remaining biomarkers were determined by ELISA. The statistical data were processed using MS Excel and MedCalc® software.
Results
The following miRNAs were studied based on the primary screen for identification of potential microRNA targets and published literature data:hsa-miR-23a-3p, hsa-miR-29c-3p, hsa-miR-30b-5p, hsa-miR-142a-5p, hsa-miR-146a-5p, hsa-miR-151a-3p.A statistically significant correlation was identified between hsa-miR-29c-3p and hsa-miR-30b-5p, hsa-miR-30b-5p and hsa-miR-151a-3p, hsa-miR-23a-3p and hsa-miR-29c-3p, hsa-miR-23a-3p and hsa-miR-151a-3p, between hsa-miR23a-3p and hsa-miR-30b-5p, between hsa-miR-142a-5p and hsa-miR-146a-5p, hsa-miR-142a-5p and hsa-miR-151a-3p as well as between hsa-miR-146a-5p and hsa-miR-151a-3p.Significant differences were observed in hsa-miR-23a-3p and hsa-miR-29c-3p among different diagnostic groups. Compared to classical biomarkers of dementia, significant correlations were observed between plasmatic amyloid-β peptide 42 and hsa-miR-29c-3p, hsa-miR-142a-5p, hsa-miR-146a-5p, hsa-miR-151a-3p. Similar correlations were also found with the plasmatic amyloid-β peptide ratio of 42/40.
Conclusions
The most promising microRNAs for differentiating among neurodegenerative diseases are hsa-miR-23a-3p and hsa-miR-29c-3p. Additionally, there is a correlation between hsa-miR-29c-3p and amyloid-β peptide and the ratio of amyloid-β peptide 42/40.While more robust studies are necessary, there could be a potential for utilizing this miRNA as a therapeutic agent in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Clinic of Neurology, University Hospital Ostrava, Ostrava, Czech Republic.
- Department of Clinical Neuroscience, University of Ostrava, Ostrava, Czech Republic.
- Department of Clinical Biochemistry, Institute of Laboratory Medicine, University Hospital Ostrava, Ostrava, Czech Republic.
- Institute of Laboratory Medicine, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
ORCID-Profile: Richard Novobilský, Pavlína Kušnierová, Petra Bártová
Förderung
- Ministerstvo Zdravotnictvà Ceské Republiky
Zitieren
APA
Novobilský, R., Kušnierová, P., Štěpán, D., Bártová, P., Stejskal, D., & Bar, M. (2025). Identification and evaluation of potential microRNA markers for diagnostics in neurodegenerative diseases and correlation with other biochemical markers. PLOS One, 20(10), e0333801. https://doi.org/10.1371/journal.pone.0333801
Vancouver
Novobilský R, Kušnierová P, Štěpán D, Bártová P, Stejskal D, Bar M. Identification and evaluation of potential microRNA markers for diagnostics in neurodegenerative diseases and correlation with other biochemical markers. PLOS One. 2025;20(10):e0333801. doi:10.1371/journal.pone.0333801
BibTeX
@article{Novobilsk2025,
author = {Novobilský, Richard and Kušnierová, Pavlína and Štěpán, Dominik and Bártová, Petra and Stejskal, David and Bar, Michal},
title = {Identification and evaluation of potential microRNA markers for diagnostics in neurodegenerative diseases and correlation with other biochemical markers},
journal = {PLOS One},
year = {2025},
volume = {20},
number = {10},
pages = {e0333801},
doi = {10.1371/journal.pone.0333801}
}
EUVIMED